Search results
Showing 7426 to 7440 of 8314 results
Discontinued Reference number: GID-TA10841
Nitazoxanide for treating the common cold in people 12 years and over [ID4049]
In development Reference number: GID-TA11128 Expected publication date: TBC
Aumolertinib for untreated EGFR mutation-positive non-small-cell lung cancer [ID4000]
In development Reference number: GID-TA10899 Expected publication date: TBC
In development Reference number: GID-TA11352 Expected publication date: TBC
In development Reference number: GID-TA11406 Expected publication date: TBC
In development Reference number: GID-TA11511 Expected publication date: TBC
In development Reference number: GID-TA11251 Expected publication date: TBC
Discontinued Reference number: GID-TA10783
Sabatolimab with azacitidine for untreated high-risk myelodysplastic syndromes [ID3996]
Discontinued Reference number: GID-TA10897
In development Reference number: GID-TA11475 Expected publication date: TBC
Nivolumab with ipilimumab for untreated unresectable stage 3 non-small-cell lung cancer [ID6248]
In development Reference number: GID-TA11253 Expected publication date: TBC
In development Reference number: GID-TA11001 Expected publication date: TBC
Repotrectinib for treating ROS1-positive advanced non-small-cell lung cancer [ID6277]
In development Reference number: GID-TA11302 Expected publication date: TBC
In development Reference number: GID-TA11366 Expected publication date: TBC
In development Reference number: GID-TA11627 Expected publication date: TBC